Previous 10 | Next 10 |
BURLINGAME, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that it will present data from its Phase 1/1b trial of mupadolimab at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Mee...
Corvus Pharmaceuticals (NASDAQ:CRVS): Q3 GAAP EPS of -$0.24 misses by $0.03. Cash, cash equivalents and marketable securities totaling $76.3M. Press Release For further details see: Corvus Pharmaceuticals EPS misses by $0.03
BURLINGAME, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the third quarter ended September 30, 2021. “Corvus is a leader in th...
Shanghai Fosun Pharma announced a $628 million deal to acquire a 73% stake in vaccine company Chengdu Antejin Biotech. Shanghai Pharma subsidiary SPH SINE acquired greater China rights for two microbiome therapies from Korea's KoBioLabs in a $110 million deal. Suzhou Innovent and ...
This month is an interesting one for penny stocks and blue-chip stocks alike. It marks the official end of the Halloween season and the start of the holidays. November also kicks off the midway part of Q4. But earnings aren’t the only thing that’s going to be at the to...
BURLINGAME, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that the IND application submitted by its partner in China, Angel Pharmaceuticals Ltd. (Angel Pharma), has been approved by the Cent...
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 PR Newswire JIAXING, China and BURLINGAME, Calif. , Oct. 25, 2021 /PRNewswire/ -- Angel Pharmaceuticals Co., Ltd. ("Angel Pharma") today announced that its IND appl...
3 Hot Penny Stocks to Watch in Mid-October 2021 With October moving by just as quickly as it started, investors continue to look for the best penny stocks to buy. But to do so involves more than just picking your favorites. Rather, investors need to do a few steps to have the best chanc...
Concerns over the resurgence of COVID-19 cases, rising Treasury yields, and high inflation made September the worst month for the major stock market indexes since the onset of the pandemic. However, shares of Onion Global (OG), Helbiz (HLBZ), Camber Energy (CEI), Corvus Pharmaceuticals (CRVS)...
The biotech industry continues to play a crucial role in developing solutions to treat critical ailments. In addition, the demand for biotech solutions is also high across other sectors such as food and agriculture. So, biotech stocks such as Leap Therapeutics (LPTX) and Corvus Pharmaceutical...
News, Short Squeeze, Breakout and More Instantly...
Corvus Pharmaceuticals Inc. Company Name:
CRVS Stock Symbol:
NASDAQ Market:
Corvus Pharmaceuticals Inc. Website:
Soquelitinib registrational Phase 3 clinical trial in PTCL advancing toward initial enrollment in Q3 2024 Fast track designation underscores unmet need for patients with relapsed or refractory PTCL, an indication with poor overall outcomes and no approved drugs based on randomized trial...
BURLINGAME, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 6, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update an...
Data demonstrated in vitro and in vivo ITK inhibition with soquelitinib induced switching of proinflammatory Th 17 cells into anti-inflammatory T reg cells Publication confirms and extends understanding of ITK inhibition mechanism of action and its potent...